Rhinitis and asthma - Manifestations of one disease

Allergy and Clinical Immunology International

Volumn 13, Issue 4, 2001, Pages 154-161

  Windom, Hugh H ^a   Togias, Alkis ^b  

^a UNIVERSITY OF SOUTH FLORIDA SARASOTA MANATEE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DECONGESTIVE AGENT; STEROID;

AIRWAY; ARTICLE; ASTHMA; ATOPY; BRONCHUS; BRONCHUS HYPERREACTIVITY; CLINICAL PRACTICE; DISEASE SEVERITY; HUMAN; IMMUNOLOGY; IMMUNOSTIMULATION; LABORATORY; LOWER RESPIRATORY TRACT; NOSE; PATHOPHYSIOLOGY; PREDICTION; RHINITIS; RISK FACTOR; STIMULUS; SYMPTOM; UPPER RESPIRATORY TRACT; UPPER RESPIRATORY TRACT INFECTION;

EID: 0034908484     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.13.4.154     Document Type: Article

References (73)

1. Mediator release after nasal airway challenge with allergen
2. Induction of nasal late phase reactions by insufflation of ragweed pollen extract
3. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions
4. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of steroid pretreatment
5. Nasal challenge with cold, dry air results in the production of inflammatory mediators: Possible mast cell involvement
6. Dry air and hyperosmolar challenge in asthma and rhinitis
7. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients
8. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics
9. Role of mast cells and basophils in rhinitis
10. Cutaneous and nasal allergic responses in ragweed hay fever: Lack of clinical and histopathologic correlations with late phase reactions
11. Eosinophils, bronchial hyperactivity and late-phase asthmatic reactions
12. Systemic immunologic and inflammatory aspects of allergic rhinitis
13. Immunohistology of the nasal mucosa following allergen-induced rhinitis
14. 2 like bronchoalveolar T-lymphocyte population in atopic asthma
15. Increases in activated T-lymphocytes, eosinophils, and cytokine messenger RNA expression for interleukin-5 and granulocyte/ macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation asthmatics
16. Cytokine messenger RNA expression for IL-4, IL-5, and granulocyte/macrophage-colony stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia
17. Detection of allergen-and mitogen-induced human cytokine transcripts using a competitive polymerase chain reaction
18. Comparison between nasal and bronchial inflammation in asthmatic and control subjects
19. Eosinophils are a feature of upper and lower airway pathology in nonatopic asthma, irrespective of the presence of rhinitis
20. Rhinitis is ubiquitous in allergic asthmatics
21. Long-term risk factors for developing asthma and allergic rhinitis: A 23-year follow-up study of college students
22. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects (results from the European community respiratory health survey)
23. Increased airway inflammation with segmental versus aerosol antigen challenge
24. Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects
25. Reticular basement membrane and lung function in COPD, asthma, and rhinitis
26. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects
27. The lack of the bronchoprotective and not the bronchodilatory ability of deep inspiration is associated with airways hyperresponsiveness
28. Airway hyperresponsiveness in asthma: A problem of limited smooth muscle relaxation with inspiration
29. The potent bronchoprotective effect of deep inspiration and its absence in asthma
30. Deep inspiration-induced bronchoprotection is stronger than bronchodilation
31. Asymptomatic bronchial hyperresponsiveness in rhinitis
32. Airway hyperresponsiveness in allergic rhinitis; a risk factor for asthma
33. Seasonal increase of bronchial reactivity in allergic rhinitis
34. Strong association of late phase reactions with asthma
35. Effects of antihistamines in adult asthma: A meta-analysis of clinical trials
36. Cetirizine in patients with seasonal rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial
37. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
38. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma
39. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy
40. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness
41. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma
42. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure
43. One daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation increase in bronchial responsiveness during the pollen season in allergic rhinitis
44. Seasonal rhinitis and asthma. Effects of tropical nasal and/or orally inhaled fluticasone proprionate. The SPIRA study
45. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis
46. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity
47. Immunotherapy reduces the risk of bronchial hyperreactivity in children with hayfever: The 2nd report from the Preventive Allergy Treatment (PAT) Study
48. Immunotherapy with a standardized dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children
49. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC (Early treatment of the atopic child)
50. Mechanisms of nose-lung interaction
51. Symptom triggers in rhinitis and asthma
52. Asthmatics with rhinosinusitis have worse upper airway disease compared to patients with rhinosinusitis alone
53. Nasal cold, dry air (CDA) challenge results in stronger nasal and pulmonary responses in asthmatics compared to patients with rhinitis
54. Experimental observations of the relationships between upper airway obstruction and pulmonary function
55. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction
56. 2 by mouth and by nose
57. Changes in bronchial responsiveness following nasal provocation with allergen
58. Effect of cetirizine on bronchial hyperresposiveness in patients with seasonal allergic rhinitis and asthma
59. The effect of nasal versus bronchial antigens (Ag) challenge on the asthmatic airways
60. Allergic rhinitis may increase asthma costs
61. Nitric oxide in the nasal airways
62. Nitric oxide, produced in the upper airways, may act in an "aerocrine" fashion to enhance pulmonary oxygen uptake in humans
63. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases
64. The effect of trigeminal resection on reflex bronchoconstriction after nasal and nasopharyngeal irritation In man
65. On nasobronchial reflex in asthmatic patients
66. Changes in airway resistance induced by nasal inhalation of cold dry, or moist air in normal individuals
67. Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma
68. Changes in airway resistance following nasal provocation
69. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis
70. Nasal provokation results in bronchial inflammation in allergic rhinitis patients
71. Nasal provocation results in bronhial inflammation in allergic rhinitis patients
72. Effect of orally inhaled budesonide in seasonal allergic rhinitis
73. Comorbid seasonal allergic rhinitis and asthma need intranasal corticosteroid for the treatment of nasal disease